Bradycardia News and Research

RSS

Bradycardia, ("heart slowness"), as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min.

Sedative dexmedetomidine may offer advantages over agents often used for sedation in ICU

Use of the sedative dexmedetomidine for critically ill patients resulted in less time on a ventilator and less delirium compared to patients administered a more commonly used drug, according to a study in the February 4 issue of JAMA, the Journal of the American Medical Association.

2 Feb 2009

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.

7 Jan 2009

FDA approves Ranexa for the treatment of chronic angina

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.

7 Nov 2008

Sedative propofol could be fatal

Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.

28 Oct 2008

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Eisai Corporation of North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.

4 Mar 2008

Prevention of primary variceal bleeding

Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of such bleeding, it can have fatal complications and is more expensive.

10 Sep 2007

Apraclonidine causes severe lethargy in infants

New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.

17 Jul 2007

Use of blockers and statins to prevent heart complications during surgery questioned

The use of drugs to prevent heart complications during surgery is called into question in this week's BMJ.

23 Jun 2007

Innovative treatment option for excessive sweating

An estimated 3 percent of the world population, or about 197 million people suffer from some form of hyperhidrosis (excessive sweating), many of whom do not receive proper diagnosis or treatment.

17 Apr 2007

Advanced Biventricular Pacemakers to all patients with AV-block?

World Congress of Cardiology Report - Pacemaker treatment for bradycardia is frequently used with more than 500,000 people worldwide receiving a cardiac pacemaker each year.

5 Sep 2006

Telemonitoring of multiple vital parameters of patients with chronic heart disease is feasible

Chronic heart failure (CHF) is a frequent syndrome with an increasing prevalence. It is a frequent cause of impeding symptoms, has a negative prognosis and absorbs about two percent of the budgets of health-care systems in the industrialized nations.

5 Sep 2005

NICE promotes use of dual-chamber pacemakers for treating bradycardia

In new medical guidance for England and Wales published today, the National Institute for Clinical Excellence (NICE) promotes the expanded use of dual-chamber pacemakers for treating slow heart rhythms, called bradycardia, which affect an estimated 100,000 people in the UK.

23 Feb 2005

Pacemakers could play a future role in protecting epilepsy patients

Results of a UK study in this week’s issue of THE LANCET highlight how interruptions to the heart’s rhythm is an under-reported consequence of epileptic seizures, and that the use of cardiac pacemakers by some epilepsy patients could play a future role in protecting against sudden unexplained death.

20 Dec 2004

Findings alleviate concerns of physicians reluctant to prescribe beta-blockers because of cardiovascular adverse effects

Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2004

Maths, not medicine, could prevent fatal heart attacks

Fatal heart attacks claims more lives than lung cancer, breast cancer and AIDS combined but it seems that maths, not medicine, holds the key to preventing these deaths among young people.

5 Jul 2004

Arrhythmias are more commonly associated with adults, they can affect children as well

Doctors prescribed different medications to control the cardiac arrhythmia, or abnormal heartbeat. But the medications slowed his heart rate too much, at times to as low as 40 beats per minute.

27 May 2004